Clinical Trial Update: A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia [Phase 1]

View source ↗

Summary

A Phase 1a/1b study of ELVN-001 for chronic myeloid leukemia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• ELVN-001

Snippet

Sponsor: Enliven Therapeutics | Conditions: Chronic Myeloid Leukemia, Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | Phase 1 | Status: RECRUITING